At 0 2 0 2 O
least 3 8 3 8 O
14 9 11 9 11 B-lower_bound
days 12 16 12 16 I-lower_bound
after 17 22 17 22 O
local 23 28 23 28 B-treatment
palliative 29 39 29 39 I-treatment
XRT 40 43 40 43 I-treatment
( 44 45 44 45 O
small 45 50 45 50 O
port 51 55 51 55 O
) 55 56 55 56 O

At 0 2 57 59 O
least 3 8 60 65 O
14 9 11 66 68 B-lower_bound
days 12 16 69 73 I-lower_bound
after 17 22 74 79 I-lower_bound
the 23 26 80 83 O
last 27 31 84 88 O
dose 32 36 89 93 O
of 37 39 94 96 O
a 40 41 97 98 O
long 42 46 99 103 B-treatment
- 46 47 103 104 I-treatment
acting 47 53 104 110 I-treatment
growth 54 60 111 117 I-treatment
factor 61 67 118 124 I-treatment

At 0 2 125 127 O
least 3 8 128 133 O
21 9 11 134 136 B-lower_bound
days 12 16 137 141 I-lower_bound
after 17 22 142 147 O
the 23 26 148 151 O
last 27 31 152 156 O
dose 32 36 157 161 O
of 37 39 162 164 O
myelosuppressive 40 56 165 181 B-treatment
chemotherapy 57 69 182 194 I-treatment

At 0 2 195 197 O
least 3 8 198 203 O
3 9 10 204 205 B-lower_bound
half 11 15 206 210 O
- 15 16 210 211 O
lives 16 21 211 216 O
of 22 24 217 219 O
the 25 28 220 223 O
antibody 29 37 224 232 O
after 38 43 233 238 O
the 44 47 239 242 O
last 48 52 243 247 O
dose 53 57 248 252 O
of 58 60 253 255 O
a 61 62 256 257 O
monoclonal 63 73 258 268 B-treatment
antibody 74 82 269 277 I-treatment

At 0 2 278 280 O
least 3 8 281 286 O
42 9 11 287 289 B-lower_bound
days 12 16 290 294 I-lower_bound
after 17 22 295 300 O
the 23 26 301 304 O
completion 27 37 305 315 O
of 38 40 316 318 O
any 41 44 319 322 O
type 45 49 323 327 O
of 50 52 328 330 O
immunotherapy 53 66 331 344 B-treatment

At 0 2 345 347 O
least 3 8 348 353 O
7 9 10 354 355 B-lower_bound
days 11 15 356 360 I-lower_bound
after 16 21 361 366 I-lower_bound
the 22 25 367 370 O
last 26 30 371 375 O
dose 31 35 376 380 O
of 36 38 381 383 O
a 39 40 384 385 O
biologic 41 49 386 394 B-treatment
agent 50 55 395 400 I-treatment

Bilirubin 0 9 401 410 B-clinical_variable
( 10 11 411 412 O
sum 11 14 412 415 O
of 15 17 416 418 O
conjugated 18 28 419 429 O
+ 29 30 430 431 O
unconjugated 31 43 432 444 O
) 43 44 444 445 O
≤ 45 46 446 447 O
1.5 47 50 448 451 B-upper_bound
x 51 52 452 453 I-upper_bound
upper 53 58 454 459 I-upper_bound
limit 59 64 460 465 I-upper_bound
of 65 67 466 468 I-upper_bound
normal 68 74 469 475 I-upper_bound
( 75 76 476 477 I-upper_bound
ULN 76 79 477 480 I-upper_bound
) 79 80 480 481 I-upper_bound
for 81 84 482 485 O
age 85 88 486 489 B-age

Concomitant 0 11 490 501 B-treatment
medications 12 23 502 513 I-treatment

Creatinine 0 10 514 524 B-clinical_variable
clearance 11 20 525 534 I-clinical_variable
or 21 23 535 537 O
radioisotope 24 36 538 550 B-clinical_variable
GFR 37 40 551 554 I-clinical_variable
≥ 41 42 555 556 O
70ml 43 47 557 561 B-lower_bound
/ 47 48 561 562 I-lower_bound
min/1.73 48 56 562 570 I-lower_bound
m² 57 59 571 573 I-lower_bound
OR 60 62 574 576 O
age 63 66 577 580 B-age
/ 66 67 580 581 O
gender 67 73 581 587 O
appropriate 74 85 588 599 O
serum 86 91 600 605 B-clinical_variable
creatinine 92 102 606 616 I-clinical_variable

Neulasta 0 8 617 625 B-treatment

No 0 2 626 628 O
evidence 3 11 629 637 O
of 12 14 638 640 O
active 15 21 641 647 O
graft 22 27 648 653 B-chronic_disease
vs. 28 31 654 657 I-chronic_disease
host 32 36 658 662 I-chronic_disease
disease 37 44 663 670 I-chronic_disease

Patient 0 7 671 678 O
must 8 12 679 683 O
not 13 16 684 687 O
have 17 21 688 692 O
had 22 25 693 696 O
prior 26 31 697 702 O
exposure 32 40 703 711 O
to 41 43 712 714 O
gene 44 48 715 719 O
vector 49 55 720 726 O
delivery 56 64 727 735 O
products 65 73 736 744 O
within 74 80 745 751 O
3 81 82 752 753 B-upper_bound
months 83 89 754 760 I-upper_bound

Patient 0 7 761 768 O
who 8 11 769 772 O
have 12 16 773 777 O
received 17 25 778 786 O
prior 26 31 787 792 O
topotecan 32 41 793 802 B-treatment
, 41 42 802 803 O
cyclophosphamide 43 59 804 820 B-treatment
, 59 60 820 821 O
or 61 63 822 824 O
both 64 68 825 829 O

Patient 0 7 830 837 O
's 7 9 837 839 O
current 10 17 840 847 O
disease 18 25 848 855 O
state 26 31 856 861 O
must 32 36 862 866 O
be 37 39 867 869 O
one 40 43 870 873 O
for 44 47 874 877 O
which 48 53 878 883 O
there 54 59 884 889 O
is 60 62 890 892 O
no 63 65 893 895 O
known 66 71 896 901 O
curative 72 80 902 910 B-treatment
therapy 81 88 911 918 I-treatment
or 89 91 919 921 O
therapy 92 99 922 929 O
proven 100 106 930 936 O
to 107 109 937 939 O
prolong 110 117 940 947 O
survival 118 126 948 956 O
with 127 131 957 961 O
an 132 134 962 964 O
acceptable 135 145 965 975 O
quality 146 153 976 983 O
of 154 156 984 986 O
life 157 161 987 991 O

Patients 0 8 992 1000 O
may 9 12 1001 1004 O
not 13 16 1005 1008 O
have 17 21 1009 1013 O
had 22 25 1014 1017 O
prior 26 31 1018 1023 B-treatment
SGT-53 32 38 1024 1030 I-treatment

Patients 0 8 1031 1039 O
must 9 13 1040 1044 O
be 14 16 1045 1047 O
> 17 18 1048 1049 O
than 19 23 1050 1054 O
12 24 26 1055 1057 B-lower_bound
months 27 33 1058 1064 I-lower_bound
and 34 37 1065 1068 O
≤ 38 39 1069 1070 O
21 40 42 1071 1073 B-upper_bound
years 43 48 1074 1079 I-upper_bound
of 49 51 1080 1082 O
age 52 55 1083 1086 B-age
at 56 58 1087 1089 O
the 59 62 1090 1093 O
time 63 67 1094 1098 O
of 68 70 1099 1101 O
study 71 76 1102 1107 O
enrollment 77 87 1108 1118 O

Patients 0 8 1119 1127 O
must 9 13 1128 1132 O
be 14 16 1133 1135 O
≥ 17 18 1136 1137 O
0.38 19 23 1138 1142 B-lower_bound
m² 24 26 1143 1145 I-lower_bound
at 27 29 1146 1148 O
the 30 33 1149 1152 O
time 34 38 1153 1157 O
of 39 41 1158 1160 O
study 42 47 1161 1166 O
enrollment 48 58 1167 1177 O

Patients 0 8 1178 1186 O
must 9 13 1187 1191 O
have 14 18 1192 1196 O
fully 19 24 1197 1202 O
recovered 25 34 1203 1212 O
from 35 39 1213 1217 O
the 40 43 1218 1221 O
acute 44 49 1222 1227 O
toxic 50 55 1228 1233 O
effects 56 63 1234 1241 O
of 64 66 1242 1244 O
all 67 70 1245 1248 O
prior 71 76 1249 1254 B-treatment
anti 77 81 1255 1259 I-treatment
- 81 82 1259 1260 I-treatment
cancer 82 88 1260 1266 I-treatment
chemotherapy 89 101 1267 1279 I-treatment

Patients 0 8 1280 1288 O
must 9 13 1289 1293 O
have 14 18 1294 1298 O
had 19 22 1299 1302 O
histologic 23 33 1303 1313 O
verification 34 46 1314 1326 O
of 47 49 1327 1329 O
malignancy 50 60 1330 1340 B-cancer
at 61 63 1341 1343 O
original 64 72 1344 1352 O
diagnosis 73 82 1353 1362 O
or 83 85 1363 1365 O
relapse 86 93 1366 1373 O

Patients 0 8 1374 1382 O
receiving 9 18 1383 1392 O
corticosteroids 19 34 1393 1408 B-treatment
who 35 38 1409 1412 O
have 39 43 1413 1417 O
not 44 47 1418 1421 O
been 48 52 1422 1426 O
on 53 55 1427 1429 O
a 56 57 1430 1431 O
stable 58 64 1432 1438 O
or 65 67 1439 1441 O
decreasing 68 78 1442 1452 O
dose 79 83 1453 1457 O
of 84 86 1458 1460 O
corticosteroid 87 101 1461 1475 O
for 102 105 1476 1479 O
at 106 108 1480 1482 O
least 109 114 1483 1488 O
7 115 116 1489 1490 B-lower_bound
days 117 121 1491 1495 I-lower_bound
prior 122 127 1496 1501 I-lower_bound
to 128 130 1502 1504 O
enrollment 131 141 1505 1515 O

Patients 0 8 1516 1524 O
who 9 12 1525 1528 O
are 13 16 1529 1532 O
currently 17 26 1533 1542 O
receiving 27 36 1543 1552 O
another 37 44 1553 1560 O
investigational 45 60 1561 1576 B-treatment
drug 61 65 1577 1581 I-treatment

Patients 0 8 1582 1590 O
who 9 12 1591 1594 O
are 13 16 1595 1598 O
currently 17 26 1599 1608 O
receiving 27 36 1609 1618 O
other 37 42 1619 1624 O
anti 43 47 1625 1629 B-treatment
- 47 48 1629 1630 I-treatment
cancer 48 54 1630 1636 I-treatment
agents 55 61 1637 1643 I-treatment

Patients 0 8 1644 1652 O
who 9 12 1653 1656 O
are 13 16 1657 1660 O
receiving 17 26 1661 1670 O
cyclosporine 27 39 1671 1683 B-treatment
, 39 40 1683 1684 O
tacrolimus 41 51 1685 1695 B-treatment
or 52 54 1696 1698 O
other 55 60 1699 1704 O
agents 61 67 1705 1711 O
to 68 70 1712 1714 O
prevent 71 78 1715 1722 O
graft 79 84 1723 1728 B-chronic_disease
- 84 85 1728 1729 I-chronic_disease
versus 85 91 1729 1735 I-chronic_disease
- 91 92 1735 1736 I-chronic_disease
host 92 96 1736 1740 I-chronic_disease
disease 97 104 1741 1748 I-chronic_disease
post 105 109 1749 1753 B-treatment
bone 110 114 1754 1758 I-treatment
marrow 115 121 1759 1765 I-treatment
transplant 122 132 1766 1776 I-treatment

Patients 0 8 1777 1785 O
who 9 12 1786 1789 O
have 13 17 1790 1794 O
an 18 20 1795 1797 O
uncontrolled 21 33 1798 1810 B-chronic_disease
infection 34 43 1811 1820 I-chronic_disease

Patients 0 8 1821 1829 O
who 9 12 1830 1833 O
have 13 17 1834 1838 O
received 18 26 1839 1847 O
a 27 28 1848 1849 O
solid 29 34 1850 1855 B-treatment
organ 35 40 1856 1861 I-treatment
transplantation 41 56 1862 1877 I-treatment

Patients 0 8 1878 1886 O
with 9 13 1887 1891 O
relapsed 14 22 1892 1900 B-cancer
or 23 25 1901 1903 I-cancer
refractory 26 36 1904 1914 I-cancer
solid 37 42 1915 1920 I-cancer
tumors 43 49 1921 1927 I-cancer

Peripheral 0 10 1928 1938 B-clinical_variable
absolute 11 19 1939 1947 I-clinical_variable
neutrophil 20 30 1948 1958 I-clinical_variable
count 31 36 1959 1964 I-clinical_variable
( 37 38 1965 1966 I-clinical_variable
ANC 38 41 1966 1969 I-clinical_variable
) 41 42 1969 1970 I-clinical_variable
≥ 43 44 1971 1972 O
1000 45 49 1973 1977 B-lower_bound
/ 49 50 1977 1978 I-lower_bound
mm³ 50 53 1978 1981 I-lower_bound

Platelet 0 8 1982 1990 B-clinical_variable
count 9 14 1991 1996 I-clinical_variable
≥ 15 16 1997 1998 O
100,000 17 24 1999 2006 B-lower_bound
/ 24 25 2006 2007 I-lower_bound
mm³ 25 28 2007 2010 I-lower_bound

SGPT 0 4 2011 2015 B-clinical_variable
( 5 6 2016 2017 I-clinical_variable
ALT 6 9 2017 2020 I-clinical_variable
) 9 10 2020 2021 I-clinical_variable
≤ 11 12 2022 2023 O
110 13 16 2024 2027 B-upper_bound
U 17 18 2028 2029 I-upper_bound
/ 18 19 2029 2030 I-upper_bound
L 19 20 2030 2031 I-upper_bound

Serum 0 5 2032 2037 B-clinical_variable
albumin 6 13 2038 2045 I-clinical_variable
≥ 14 15 2046 2047 O
2 16 17 2048 2049 B-lower_bound
g 18 19 2050 2051 I-lower_bound
/ 19 20 2051 2052 I-lower_bound
dL 20 22 2052 2054 I-lower_bound

at 0 2 2055 2057 O
least 3 8 2058 2063 O
84 9 11 2064 2066 B-lower_bound
days 12 16 2067 2071 I-lower_bound
must 17 21 2072 2076 O
have 22 26 2077 2081 O
elapsed 27 34 2082 2089 O
after 35 40 2090 2095 O
transplant 41 51 2096 2106 B-treatment
or 52 54 2107 2109 O
stem 55 59 2110 2114 B-treatment
cell 60 64 2115 2119 I-treatment
infusion 65 73 2120 2128 I-treatment

breast 0 6 2129 2135 O
- 6 7 2135 2136 O
feeding 7 14 2136 2143 O
women 15 20 2144 2149 B-gender

pregnant 0 8 2150 2158 B-pregnancy

primary 0 7 2159 2166 B-cancer
central 8 15 2167 2174 I-cancer
nervous 16 23 2175 2182 I-cancer
system 24 30 2183 2189 I-cancer
tumors 31 37 2190 2196 I-cancer

tumor 0 5 2197 2202 B-treatment
vaccines 6 14 2203 2211 I-treatment

